Cloning, yeast expression, purification and biological activity of a truncated form of the soybean 7S globulin α' subunit involved in Hep G2 cell cholesterol homeostasis

Journal of Nutritional Biochemistry

Volumn 21, Issue 9, 2010, Pages 887-891

  Consonni, Alessandro ^a   Lovati, Maria Rosa ^a   Manzoni, Cristina ^a   Pizzagalli, Anna ^a   Morazzoni, Paolo ^b   Duranti, Marcello ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b INDENA S P A   (Italy)

Author keywords

7S Soybean proteins; Cell cholesterol homeostasis; Chain; Hep G2 cells; LDL Receptors; Truncated '

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; RECOMBINANT PROTEIN; SIMVASTATIN; SOYBEAN 7S GLOBULIN ALPHA; UNCLASSIFIED DRUG;

AMINO ACID ANALYSIS; AMINO TERMINAL SEQUENCE; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; GENE EXPRESSION; HOMEOSTASIS; HUMAN; HUMAN CELL; LIPID DEGRADATION; LIPOPROTEIN METABOLISM; MOLECULAR CLONING; NONHUMAN; PICHIA PASTORIS; POLYMERASE CHAIN REACTION; PROMOTER REGION; PURIFICATION; YEAST;

AMINO ACID SEQUENCE; ANTIGENS, PLANT; CHOLESTEROL; CLONING, MOLECULAR; GLOBULINS; HEP G2 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; PICHIA; PROTEIN SUBUNITS; SEED STORAGE PROTEINS; SOYBEAN PROTEINS;

GLYCINE MAX; PICHIA PASTORIS;

EID: 77955841344     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2009.07.003     Document Type: Article

References (23)

1. Sirtori C.R., Lovati M.R. Soy protein and cardiovascular disease. Curr Atheroscler Rep 2001, 3:47-53.
2. Lovati M.R., Manzoni C., Corsini A., Granata A., Frattini R., Fumagalli R., et al. Low-density receptor activity is modulated by soybean globulins in cell culture. J Nutr 1992, 122:1971-1978.
3. Manzoni C., Duranti M., Eberini I., Scharnagl H., Maerz W., Castiglioni S., et al. Subcellular localization of soybean 7S globulin in Hep G2 cells and LDL receptor up-regulation by its α' constituent subunit. J Nutr 2003, 133:2149-2155.
4. Duranti M., Lovati M.R., Dani V., Barbiroli A., Scarafoni A., Castiglioni S., et al. The α' subunit from soybean 7S globulin lowers plasma lipids and upregulates liver β-VLDL receptors in rats fed a hypercholesterolemic diet. J Nutr 2004, 134:1334-1339.
5. Thanh V.H., Shibasaki K. Heterogeneity of beta-conglycinin. Biochim Biophys Acta 1976, 439:326-338.
6. Maruyama N., Sato R., Matsumura Y., Goto H., Okuda E., Nakagawa S., et al. Structure-physicochemical function relationships of soybean beta-conglycinin constituent subunits. J Agric Food Chem 1999, 47:5278-5284.
7. Sirtori C.R., Lovati M.R., Manzoni C., Gianazza E., Bondioli A., Staels B., et al. Reduction of serum cholesterol by soy proteins: clinical experience and potential molecular mechanisms. Nutr Metab Cardiovasc Dis 1998, 8:334-340.
8. Lovati M.R., Manzoni C., Gianazza E., Sirtori C.R. Soybean protein products as regulators of liver-low density lipoprotein receptors: I. Identification of active β-conglycinin subunits. J Agric Food Chem 1998, 46:2474-2480.
9. Lovati M.R., Manzoni C., Gianazza E., Arnoldi A., Kurowska E., Carroll K.K., et al. Soy protein peptides regulate cholesterol homeostasis in Hep G2 cells. J Nutr 2000, 130:2543-2549.
10. Lovati M.R., Manzoni C., Castiglioni S., Disconzi E. Soy peptide and cholesterol homeostasis. FASEB J. 2006, LB 391:86.
11. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:660-665.
12. Havel R.Y., Eder H.A., Bradgon J.H. The distribution of centrifugally separated lipoproteins in human serum. J Clin Invest 1955, 34:1345-1353.
13. Bilheimer D.W., Eisenberg S., Levy R.I. The metabolism of very low density lipoprotein proteins: I. Preliminary in vitro and in vivo observations. Biochim Biophys Acta 1972, 260:212-221.
14. Sirtori C.R., Eberini I., Arnoldi A. Hypocholesterolaemic effects of soya proteins: results of recent studies are predictable from the Anderson meta-analysis data. Brit J Nutr 2007, 97:816-822.
15. Lovati M.R., Manzoni C., Agostinelli P., Ciappellano S., Mannucci L., Sirtori C.R. Studies on the mechanism of the cholesterol lowering activity of soy proteins. Nutr Metab Cardiovasc Dis 1991, 1:18-24.
16. Lovati M.R., Manzoni C., Canavesi A., Sirtori M., Vaccarini V., Marchi M., et al. Soybean protein diet increases low-density lipoprotein receptor activity in mononuclear cells from hypercholesterolemic patients. J Clin Invest 1987, 80:1498-1502.
17. Kitts D.D., Weiler K. Bioactive proteins and peptides from food sources. Application bioprocess used in isolation and recovery. Curr Pharm Des 2003, 9:1309-1323.
18. Wan X.S., Serota D.G., Ware J.H., Crowell J.A., Kennedy A.R. Detection of Bowman-Birk inhibitor and anti-Bowman-Birk inhibitor antibodies in sera of humans and animals treated with Bowman-Birk inhibitor concentrate. Nutrition and Cancer 2002, 43:167-173.
19. Clemente A., Domoney C. Therapeutic properties of legume protease inhibitors from the Bowman-Birk family. Recent Prog Med Plants 2008, 20:397-417.
20. Matoba N., Doyama N., Yamada Y., Maruyama N., Utsumi S., Yoshikawa M. Design and production of genetically modified soybean protein with anti-hypertensive activity by incorporating potent analogue of ovokinin (2-7). FEBS Lett 2001, 497:50-54.
21. Cho S.J., Juillerat M.A., Lee C.H. Identification of LDL-receptor transcription stimulating peptides from soybean hydrolysate in human hepatocytes. J Agric Food Chem 2008, 56:4372-4376.
22. Castiglioni S., Manzoni C., D'Uva A., Spiezie R., Monteggia E., Chiesa G., et al. Soy proteins reduce progression of a focal lesion and lipoprotein oxidizability in rabbits fed a cholesterol-rich diet. Atherosclerosis 2003, 171:163-170.
23. Sirtori C.R. Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. Drug Safety 2001, 24:665-682.